Works matching IS 19466234 AND DT 2023 AND VI 15 AND IP 695

Results: 5
    1
    2

    A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.abp9229
    By:
    • Melero, Ignacio;
    • Tanos, Tamara;
    • Bustamante, Mariana;
    • Sanmamed, Miguel F.;
    • Calvo, Emiliano;
    • Moreno, Irene;
    • Moreno, Victor;
    • Hernandez, Tatiana;
    • Martinez Garcia, Maria;
    • Rodriguez-Vida, Alejo;
    • Tabernero, Josep;
    • Azaro, Analia;
    • Ponz-Sarvisé, Mariano;
    • Spanggaard, Iben;
    • Rohrberg, Kristoffer;
    • Guarin, Ernesto;
    • Nüesch, Eveline;
    • Davydov, Iakov I.;
    • Ooi, Chiahuey;
    • Duarte, José
    Publication type:
    Article
    3

    Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 695, p. 1, doi. 10.1126/scitranslmed.adg7404
    By:
    • Feng, Yupeng;
    • Yuan, Meng;
    • Powers, John M.;
    • Hu, Mengyun;
    • Munt, Jennifer E.;
    • Arunachalam, Prabhu S.;
    • Leist, Sarah R.;
    • Bellusci, Lorenza;
    • Kim, JungHyun;
    • Sprouse, Kaitlin R.;
    • Adams, Lily E.;
    • Sundaramurthy, Sumana;
    • Zhu, Xueyong;
    • Shirreff, Lisa M.;
    • Mallory, Michael L.;
    • Scobey, Trevor D.;
    • Moreno, Alberto;
    • O'Hagan, Derek T.;
    • Kleanthous, Harry;
    • Villinger, Francois J.
    Publication type:
    Article
    4
    5